![Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports. Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.](https://data.cbonds.info/organisations_logos/13739/1506089713teva.png)
Teva Pharmaceutical Industries. Information about the issuer. (LEI 549300BAFGM4RC74ZJ94, SWIFT TEVPILITXXX). News and credit ratings. Tables with accounting and financial reports.
Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg
![Berkshire Hathaway Inc ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io Berkshire Hathaway Inc ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-berkshire-hathaway.png)
Berkshire Hathaway Inc ownership in TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
![ARK Investment Management LLC reports 21.16% decrease in ownership of TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io ARK Investment Management LLC reports 21.16% decrease in ownership of TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io](https://images.fintel.io/us-TEVA-ark-investment-management.png)
ARK Investment Management LLC reports 21.16% decrease in ownership of TEVA / Teva Pharmaceutical Industries Ltd. - 13F, 13D, 13G Filings - Fintel.io
![Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg Tear Sheet: Teva Pharmaceuticals Faces Pressure From Competing Generics, Seeks to Delever Quickly After Actavis Acquisition - Reorg](http://reorg-research.com/images/Teva+Org+Chart.png)